Where does Bard Peripheral Vascular, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bard Peripheral Vascular, Inc. ranks #3,273 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bard Peripheral Vascular, Inc. hold?

Bard Peripheral Vascular, Inc. holds 114 US utility patents granted between 2015 and 2025, spanning 26 technology areas.

What is Bard Peripheral Vascular, Inc.'s Innovation Score?

Bard Peripheral Vascular, Inc. has an Innovation Score of 51.3 out of 100 (top 12% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bard Peripheral Vascular, Inc. focus on?

Bard Peripheral Vascular, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 71 patents, ranking #257 of 7,127 assignees active in that subclass. Grants appear in 26 CPC subclasses total.

Is Bard Peripheral Vascular, Inc.'s patent grant rate increasing or decreasing?

Bard Peripheral Vascular, Inc.'s recent grant velocity is +17% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Bard Peripheral Vascular, Inc.'s patents?

Bard Peripheral Vascular, Inc.'s patents average 15.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bard Peripheral Vascular, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Bard Peripheral Vascular, Inc.

USPTO PatentsView assignee record - 114 granted patents across 26 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bard ranks #3,273 of 49,997 tracked US assignees by granted-patent volume, with 114 patents across 26 technology areas.

#3,273
of 49,997 US assignees by volume: Top 12%
by Innovation Score (51.3/100): 15.6
avg claims per patent: +17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3273 · US Corporation #3,273 · 114 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 114 grants
TOP-DECILE #3,273/49,997
PHOTO-FINISH Abbyy Development
CPC-FOCUS A61B · 26 areas
INNOV-PAR 51.3/100
CLAIMS-RICH 15.6 claims/avg
TYPE-USCORP US Corporation
VEL-UP +17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Abbyy Development Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bard’s 51.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.4 pts (32%) Velocity 7.5 pts (15%) Breadth 18.0 pts (35%) Claim depth 9.4 pts (18%)

Qualcomm Incorporated · highest

85
Bard Peripheral… · this assignee

51
Guardian Industries · near

51
Hill's Pet Nutrition · near

51
iLOQ Oy · near

51
Zoll Circulation · near

51
3D Lighting… · lowest

7

What this shows Bard's Innovation Score is 51.3/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bard?

Each dot is one of Bard’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bard’s own 15.6 claims/patent is at or below the 17.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Bard vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bard's grants concentrate

Bard Peripheral Vascular, Inc. is a focused PatentsView assignee: 26 CPC subclasses with 62.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (17 grants) versus a trough of 6 in 2017. By volume, Bard sits between UTI Inc. and Equinor Energy AS.

Bard's three-year grant acceleration

From 2019–2021 to 2022–2024, Bard Peripheral Vascular, Inc. moved from 32 to 36 grants (1.13x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #912. See the growth leaderboard.

UTI

115
Abbyy Development

114
Asana

114
Baidu COM Times T…

114
Chia Tai Tianqing…

114
Creeled

114
Dreamwell

114
Equinor Energy AS

114
Bard Peripheral V… ◀

114

What this shows Bard holds 114 patents at rank #3,273, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bard

By rank, the assignees closest to #3,273 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Bard's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bard, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Bard ranks #257 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (51 here).

Zoll Circulation, Inc. 51 Guardian Industries Corp. 51 Hill's Pet Nutrition, Inc. 51 iLOQ Oy 51

Similar claim depth

Nearest assignees by average claims per patent (15.6 here).

VKR Holding A/S 15.6 avg Shpp Global Technologies B.V. 15.6 avg Cellectis 15.6 avg Toshiba Memory Corporation 15.6 avg

Bard's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Bard Peripheral Vascular, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	7.0%
2016	9	7.9%
2017	6	5.3%
2018	9	7.9%
2019	14	12.3%
2020	11	9.6%
2021	7	6.1%
2022	8	7.0%
2023	11	9.6%
2024	17	14.9%
2025partial year	14	12.3%

Which technologies does Bard Peripheral Vascular, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 71

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 69

Y10T - Technical Subjects Covered BY Former US Classification 28

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 11

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 11

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 9

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 9

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 7

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 7

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

D04C - Braiding OR Manufacture OF Lace, Including Bobbin-net OR Carbonised LACE; Braiding MACHINES; BRAID; Lace 5

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 4

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 3

Top 15 of 26 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bard Peripheral Vascular, Inc.'s patent record in context - here's where to go next.

Bard Peripheral Vascular, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 62.3% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #3,273 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bard Peripheral Vascular, Inc. against UTI Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 51.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.